申请人:The Regents of the University of Michigan
公开号:US11226333B2
公开(公告)日:2022-01-18
The present disclosure relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present disclosure relates to cancer markers as diagnostic markers and clinical targets for lung cancer.
本公开涉及用于癌症诊断、研究和治疗的组合物和方法,包括但不限于癌症标记物。特别是,本公开涉及作为肺癌诊断标志物和临床靶点的癌症标志物。